Tag Archives: covid-19 vaccine

Moderna vaccine generates more antibodies than covid-19

[ad_1] Three months after the second dose (administered 28 days after the first), participants in Moderna’s covid-19 vaccine study demonstrated high levels of antibodies. “This suggests that the vaccine will provide lasting immunity,” the lead researcher said. A new study recently published in The New England Journal of Medicine suggests …

Read More »

IBM denounces “high-precision” cyber attacks on vaccine distribution

[ad_1] JN / Agencies Yesterday at 11:51 pm IBM has detected a campaign of “high-precision” cyberattacks against the cold chain that will help facilitate the distribution of vaccines against covid-19. The series of attacks, detected by an investigation by the cybercrime department of that American technology company, began in September …

Read More »

A participant in clinical trials for the COVID vaccine describes the side effects. “It doesn’t last long. It’s worse if you don’t get vaccinated.”

[ad_1] Yasir Batalvi, a young participant in clinical trials for the COVID-19 vaccine developed by the pharmaceutical company Moderna, spoke in an interview on CNN about the side effects he experienced after being vaccinated. “30 minutes after receiving the vaccine, I felt pain and numbness in my arm. As if …

Read More »

Could a new mutation in the SARS-CoV-2 virus reduce the effectiveness of vaccines?

[ad_1] Health 14:31 28.11.2020(updated 15:28 28.11.2020) Short URL https://cdnfr1.img.sputniknews.com/img/07e4/0b/1c/1044846648_0:-1:1920:1080_1200x675_80_0_0_5502392f9e4a881a267cbb71bd2c266f.jpg Sputnik France https://cdnfr2.img.sputniknews.com/i/logo.png Youlia Zvantsova. Sputnik France https://fr.sputniknews.com/sante/202011281044846685-une-nouvelle-mutation-du-virus-sras-cov-2-pourrait-elle-reduire-lefficacite-des-vaccins/ Scientists are working hard to develop an effective Covid-19 vaccine, but a recently discovered mutant strain could dampen the effectiveness of some. As the world grapples with developing a vaccine for Covid-19, some …

Read More »

Half the dose was given to young people

[ad_1] The lower dose of COVID vaccine, 90% effective during clinical trials conducted by Oxford and AstraZeneca, was given to younger subjects than the higher dose, which showed lower efficacy, says Operation Warp Speed ​​chief. Moncef Slaoui, quoted by Bloomberg. The vaccine developed with the University of Oxford has been …

Read More »